Full Text View
Tabular View
Study Results
Related Studies
Short Term Safety and Efficacy of Lubiprostone in Adults With Cystic Fibrosis
This study has been completed.
Study NCT00706004   Information provided by University of Arkansas

First Received on June 25, 2008.   Last Updated on March 14, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Constipation
Cystic Fibrosis
Additional conditions recognized in this trial
Fibrosis
More general conditions related to this trial
Digestive System Diseases
Genetic Diseases, Inborn
Infant, Newborn, Diseases
Lung Diseases
Pancreatic Diseases
Pathologic Processes
Respiratory Tract Diseases
Signs and Symptoms
Signs and Symptoms, Digestive
Interventions listed in this trial
lubiprostone
Sponsors listed in this trial
University of Arkansas
Takeda Pharmaceuticals North America, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services